Close Menu

Abbott

The UCSF Viral Diagnostics and Discovery Center will use sequencing, microarrays, and other genomic technologies to characterize pathogens linked to acute and chronic human illnesses.

The suit revolves around patents owned by UNeMed, the technology-transfer organization for the UN Medical Center, and exclusively licensed to Abbot Laboratories, though Abbott is not listed as a co-plaintiff on the complaint.

The California District court denied motions for summary judgment of invalidity of Abbott's in situ DNA hybridization patent.

LGC will develop clinical and non-clinical applications for the Ibis T5000 Biosensor System.

Snippets: Apr 1, 2009

Premium

Epigenomics, Response Genetics, Exact Sciences

Shaun Lonergan

Paired Ends: Mar 10, 2009

Premium

Kevin Ulmer, Patrick Soon-Shiong, Shaun Lonergan

William Moffitt signed a three-year contract to remain president and CEO of Nanosphere, while BioTrove's Al Luderer joined Agendia's supervisory board, and more.

Paired Ends: Mar 3, 2009

Premium

Mort Minaee, Jay Flatley, Mari Baker

Pages

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.